A recent commentary explored the economic burden of pneumonia, diarrhea, and measles for households in Uganda. These are the three common and severe illnesses among infants and young children. The Decade of Vaccine Economics (DOVE) project, which is wrapping up in Bangladesh and Uganda, conducted the first-ever cost-of-illness study to estimate the economic burden of pneumonia, diarrhea and measles from the household and societal perspectives in Uganda. Policy makers are taking notice.
The Decade of Vaccine Economics (DOVE) project at IVAC-JHSPH published a new methodology report, developed collaboratively with DOVE-ROI Core Advisory Group members from 9 institutions to support Gavi’s mid-term review and investment case.
Did you know that the models developed by the DOVE project estimate the costs averted by vaccination? The models focuses on ten antigens and 94 low- and middle-income countries, 2001-2030. Results are used at the global and regional level to advocate for new vaccine introduction and increased coverage.
A recent commentary by the DOVE project explored the economic burden of pneumonia, diarrhea, and measles for households in Uganda. This is the first-ever study of such kind in Uganda, and policy makers are taking notice
Local engagement and empowerment have been essential for the DOVE study to develop cost of illness estimates and apply them to policymaking and program planning in Uganda. Here are some ideas and tools you can use...
Research helps stakeholders in Bangladesh and other countries make more informed decisions about the true economic burden of childhood diseases and better evaluate investments in vaccines. Read more here